期刊文献+

非小细胞肺癌组织中ETS-1和U-PA的表达及意义 被引量:1

Expression and Significance of ETS-1 and U-PA in Non-small Cell Lung Cancer
下载PDF
导出
摘要 ETS-1(E26transformation specific-1)可以上调U-PA(urokinase-type plasminogen activator)的表达,但两者相关性的大小尚不清楚.通过采用免疫组化和RT-PCR(reverse transcriptase polymerase chain reaction)检测非小细胞肺癌(non-small cell lung cancer,NSCLC)和癌旁正常组织中ETS-1和U-PA的表达.免疫组化结果显示,50例NSCLC组织中,ETS-1和U-PA蛋白阳性率分别为70%(35/50)和64%(32/50),均显著高于对应的癌旁正常组织15%(3/20)和10%(2/20)(P<0.001).ETS-1阳性率随着肿瘤侵润深度的增加,淋巴结转移和临床分期的增加而增加(P<0.05).U-PA阳性率随着淋巴结转移和临床分期的增加而增加(P<0.05).ETS-1和U-PA蛋白表达呈正相关(r=0.059,P<0.01).在17例癌组中和癌旁组中,ETS-1、U-PA mRNA的相对表达强度分别为(0.564±0.059)和(0.318±0.089)(P=0.000)、(0.773±0.191)和(0.401±0.193)(P=0.000).结果表明,ETS-1和U-PA的过量表达与NSCLC的发展密切相关,两者的表达呈正相关,ETS-1可能通过上调U-PA的表达,促进肺癌的进展. U-PA expression can be up-regulated by ETS-1,but the value of their relationship was not clear.The expression of ETS-1and U-PA in non-small cell lung cancer(NSCLC)and normal tissues were detected by immunohistochemistry and RT-PCR.Immunohistochemical staining showed that the expression rate of ETS-1 and U-PA protein in NSCLC tissue were 70%(35 /50) and 64%(32 /50),which is significantly higher than that in the normal tissues,15%(3 /20)and 10%(2 /20)(P 0.001),respectively.The expression rate of ETS-1 protein was increased in deeper of invasion,lymph node metastasis and higher clinical stages (P 0.05)of NSCLC.The expression rate of U-PA protein was increased in lymph node metastasis and higher clinical stages(P0.05)of NSCLC.A positive correlation between the expression of ETS-1 and U-PA protein was found(r=0.509,P0.01).The relative expression intensity of ETS-1and U-PA mRNA in 17 NSCLC tissues were(0.564 ± 0.059)and(0.773 ± 0.191),significantly higher than that in corresponding normal tissues((0.318±0.089)(P=0.000),and(0.401±0.193)(P=0.000)).The results indicated that the progression of NSCLC was correlated closely with over-expression of ETS-1 and U-PA.There was a positive correlation between the expression of ETS-1 and U-PA protein.ETS-1 might be involved in progression of NSCLC via up-regulating the expression of U-PA.
出处 《生命科学研究》 CAS CSCD 2010年第5期436-441,共6页 Life Science Research
基金 国家自然科学基金资助项目(30871137)
关键词 非小细胞肺癌(NSCLC) ETS-1 U-PA 侵润和转移 non-small cell lung cancer(NSCLC) ETS-1 U-PA invasion and metastasis
  • 相关文献

参考文献16

  • 1MOLINA J R,YANG P,CASSIVI S D,et al.Non-small cell lung cancer:epidemiology,risk factors,treatment,and survivorship[J].Mayo Clinic Proceedings,2008,83(5):584-594.
  • 2DITTMER J,VETTER M,BLUMENTHAL S G,et al.Importance of ETS-1 proto-oacogene for breast cancer progression[J].Zentralbl Gynakol,2004,126(4):269-271.
  • 3SALNIKOW K,APRELIKOVA O,IVANOV S,et al.Regulation of hypoxia-inducible genes by ETS-1 transcription facter[J].Carcinogenesis,2008,29(8):1493-1499.
  • 4HAHNE J C,OKUDUCU A F,SAHIN A,et al.The transcription factor ETS-1:its role in tumor development and strategies for its inhibition[J].Mini Reviews in Medicinal Chemistry,2008,8(11):1095-1105.
  • 5任涛文,周永宁,吴静,张志镒,郝天军,王娟霞,邹绍静,陈兆峰,黄珊珊,张俐花,赵越.胃癌组织中Ets-1的表达及其与血管生成临床病理特征和预后的关系[J].中华肿瘤杂志,2009,31(9):674-678. 被引量:9
  • 6SATO T,MIWA A.ETS-1 and integrin beta3 for lung metastasis from colorectal cancer[J].APMIS,2002,110(4):347-353.
  • 7DAVIDSON B,REICH R,GOLDBERG I,et al.ETS-1 messenger RNA expression is a novel marker of poor survival in ovarian carcinoma[J].Clinical Cancer Research,2001,7(3):551-557.
  • 8YAMAGUCHI E,NAKAYAMA T,NANASHIMA A,et al.ETS-1 proto-oncogene as a potential predictor for poor prognosis of lung adenocarcinoma[J].The Tohoku Journal of Experimental Medicine,2007,213(1):41-50.
  • 9TAKANAMI I,TAKEUCHI K,KARUKE M.Expression of ETS-1 is correlated with urokinasetype plasminogen activator and poor prognosis in pulmonary adenocarcinoma[J].Tumour Biology,2001,22(4):205-210.
  • 10李竹林,朱明才,董蒲江.结肠癌中VEGF-D和uPA的表达与侵袭转移的关系[J].第三军医大学学报,2008,30(22):2146-2149. 被引量:11

二级参考文献79

共引文献49

同被引文献7

  • 1Jema A, Bray F, Center MM, et al. Global Cancer Statistics [J]. CA Cancer J Clin,2011,61(2) :69-90.
  • 2Corte MD, Gonzalez LO, Corte MG, et al. Collagenase-3 ( MMP -13 ) expression in cutaneous malignant melanoma[J], Int J Biol Markers, 2005,20 (4) : 242-8.
  • 3Huang MY,Chang HJ,Chung FY,et al. MMP13 is a potential prognostic marker for colorectal cancer[J]. Oncol Rep, 2010, 24(5) : 1241-7.
  • 4Stokes A,Joutsa J, Ala Aho R, et al. Expression proflies and clinical correlations of degradome components in the tumor microenvironment of head and neck squamous cell carcinoma [J]. Clin Cancer Res,2010,16 (7) :2022-35.
  • 5Chang H J, Yang M J, Yang YH, et al. MMP13 is potentially a new tumor marker for breast cancer diagnosis[J]. Oncol Rep, 2009,22 (5) : 1119-27.
  • 6Hsu CP, Shen GH, Ko JL. Matrix metalloproteinase-13 expres sion is associated with bone marrow microinvolvement and prognosis in non-small cell lung cancer[J]. Lung Cancer, 2006,52 (3) :349-57.
  • 7苏颖颖,朱恩新,马卫东,肖晶,刘婷姣.c-fos及基质金属蛋白酶13在人口腔鳞状细胞癌发生中的表达及病理意义[J].口腔医学研究,2009,25(1):23-25. 被引量:8

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部